Ana Radeljevic
Directeur/Bestuurslid bij MERRIMACK PHARMACEUTICALS, INC.
Actieve functies van Ana Radeljevic
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 06-06-2022 | - |
| Independent Dir/Board Member | 06-06-2022 | - | |
ADRx, Inc.
 ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01-09-2021 | - |
Loopbaan van Ana Radeljevic
Eerdere bekende functies van Ana Radeljevic
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REVVITY, INC. | Corporate Officer/Principal | 01-01-2014 | 01-01-2016 |
Opleiding van Ana Radeljevic
| Syracuse University | Masters Business Admin |
| Old Dominion University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REVVITY, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Health Technology |
- Beurs
- Insiders
- Ana Radeljevic
- Ervaring
